210 related articles for article (PubMed ID: 9524622)
1. [3D-Ct-planned interstitial HDR brachytherapy + percutaneous irradiation and chemotherapy in inoperable pancreatic carcinoma. Methods and clinical outcome].
Pfreundner L; Baier K; Schwab F; Willner J; Bratengeier K; Flentje M; Feustel H; Fuchs KH
Strahlenther Onkol; 1998 Mar; 174(3):133-41. PubMed ID: 9524622
[TBL] [Abstract][Full Text] [Related]
2. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
3. Combined isodose curves of high-dose rate interstitial brachytherapy with external-beam radiation therapy in pancreatic carcinoma.
Warszawski N; Pfreundner L; Bratengeier K; Bohndorf W; Feustel H
Strahlenther Onkol; 1992 Sep; 168(9):552-7. PubMed ID: 1384154
[TBL] [Abstract][Full Text] [Related]
4. Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study.
Prott FJ; Schönekaes K; Preusser P; Ostkamp K; Wagner W; Micke O; Pötter R; Sulkowski U; Rübe C; Berns T; Willich N
Br J Cancer; 1997; 75(4):597-601. PubMed ID: 9052417
[TBL] [Abstract][Full Text] [Related]
5. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.
Harrison LB; Minsky BD; Enker WE; Mychalczak B; Guillem J; Paty PB; Anderson L; White C; Cohen AM
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):325-30. PubMed ID: 9788411
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
9. Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: a phase I-II study.
Nori D; Merimsky O; Osian AD; Heffernan M; Cortes E; Turner JW
J Surg Oncol; 1996 Apr; 61(4):300-5. PubMed ID: 8628003
[TBL] [Abstract][Full Text] [Related]
10. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
[TBL] [Abstract][Full Text] [Related]
12. CT-guided high-dose-rate brachytherapy in the interdisciplinary treatment of patients with liver metastases of pancreatic cancer.
Wieners G; Schippers AC; Collettini F; Schnapauff D; Hamm B; Wust P; Riess H; Gebauer B
Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):530-8. PubMed ID: 26459730
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
14. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
[TBL] [Abstract][Full Text] [Related]
15. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
Morganti AG; Valentini V; Macchia G; Mattiucci GC; Costamagna G; Deodato F; Smaniotto D; Luzi S; Balducci M; Barbi S; Perri V; Trodella L; Cellini N
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1454-60. PubMed ID: 15275732
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of a T1 cancer of the pancreatic head with high dose rate brachytherapy and external radiotherapy.
Takácsi-Nagy Z; Varga J; Poller I; Fodor J; Polgár C; Petrányi A; Major T; Németh G
Hepatogastroenterology; 2002; 49(45):844-6. PubMed ID: 12064004
[TBL] [Abstract][Full Text] [Related]
17. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
[TBL] [Abstract][Full Text] [Related]
18. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
Mutignani M; Shah SK; Morganti AG; Perri V; Macchia G; Costamagna G
Endoscopy; 2002 Jul; 34(7):555-9. PubMed ID: 12170409
[TBL] [Abstract][Full Text] [Related]
19. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.
Yorozu A; Dokiya T; Oki Y
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):271-5. PubMed ID: 10487545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
